Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report)’s stock price was down 6.3% during mid-day trading on Tuesday . The company traded as low as $75.00 and last traded at $75.00. Approximately 636 shares changed hands during trading, an increase of 97% from the average daily volume of 323 shares. The stock had previously closed at $80.00.
Bioqual Trading Down 6.3 %
The stock’s 50-day moving average is $75.14 and its two-hundred day moving average is $68.34.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last issued its earnings results on Tuesday, January 23rd. The company reported $0.54 EPS for the quarter. Bioqual had a negative net margin of 0.76% and a negative return on equity of 1.22%. The firm had revenue of $15.87 million during the quarter.
About Bioqual
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Stories
- Five stocks we like better than Bioqual
- P/E Ratio Calculation: How to Assess Stocks
- 4 Golden Crosses With Double-Digit Upside Ahead
- Basic Materials Stocks Investing
- All-Aboard! Greenbrier Companies Breaks Out, New Highs Ahead
- Transportation Stocks Investing
- 3 High Dividend Socks to Replace Lower Savings Yields Ahead
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
